Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by

K F Shen1, S M Crain

  • 1Dept. of Neuroscience, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461.

Brain Research
|August 20, 1990
PubMed

Insights

Cholera toxin (CTX) blocks excitatory opioid effects on dorsal root ganglion (DRG) neuron action potential duration (APD). This suggests opioid receptors use the cyclic AMP pathway, impacting pain signaling.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Opioid receptors modulate dorsal root ganglion (DRG) neuron action potential duration (APD).
  • Excitatory opioid receptors are linked to cyclic AMP-dependent pathways.
  • Inhibitory opioid receptors involve pertussis toxin-sensitive Gi/Go proteins.

Purpose of the Study:

  • To investigate if excitatory opioid receptors couple to the adenylate cyclase/cyclic AMP system via Gs proteins.
  • To determine the role of cholera toxin (CTX) and its A subunit (CTX-A) in modulating opioid receptor signaling in DRG neurons.

Main Methods:

  • DRG neurons were pretreated with low concentrations of CTX or CTX-A.
  • Action potential duration (APD) changes induced by opioids were measured.
  • Blocking effects of CTX/CTX-A on opioid-induced APD prolongation were assessed.

Main Results:

  • Remarkably low concentrations of CTX or CTX-A blocked opioid-induced APD prolongation in 29 out of 30 DRG neurons.
  • APD shortening by inhibitory opioids remained unaffected.
  • Blocking effects were reversed upon removal of CTX/CTX-A.

Conclusions:

  • Excitatory opioid receptors in DRG neurons likely couple positively to the Gs-adenylate cyclase-cyclic AMP system.
  • CTX and CTX-A exhibit potent blocking effects on this excitatory opioid pathway.
  • Further biochemical analysis is needed to elucidate the precise mechanisms.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...